US Stock MarketDetailed Quotes
CLNN Clene
- 5.4000
- -0.1600-2.88%
Trading Oct 21 12:14 ET
43.00MMarket Cap-1758P/E (TTM)
5.5428High5.3691Low23.47KVolume5.5500Open5.5600Pre Close128.48KTurnover0.50%Turnover RatioLossP/E (Static)7.96MShares12.000052wk High-85.71P/B25.49MFloat Cap3.818152wk Low--Dividend TTM4.72MShs Float356.4000Historical High--Div YieldTTM3.12%Amplitude3.8180Historical Low5.4740Avg Price1Lot Size
Clene Stock Forum
Sign in to post a comment
$Clene (CLNN.US)$ IBN Coverage: Clene (NASDAQ: CLNN) Announces Series of Direct Offerings, Concurrent Private Placements
Wed, Oct 2, 2024 at 7:21 AM EDT
This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the investment community.
LOS ANGELES, CA - (NewMediaWire) - October 2, 2024 - Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal functio...
Wed, Oct 2, 2024 at 7:21 AM EDT
This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the investment community.
LOS ANGELES, CA - (NewMediaWire) - October 2, 2024 - Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal functio...
$Clene (CLNN.US)$ who tf selling it off??
1
$Clene (CLNN.US)$
Clene Announces New CNM-Au8® Biomarker and Clinical Efficacy Data Submitted to FDA In Support of Treatment For ALS
Clene Inc. (Nasdaq: CLNN) has submitted new CNM-Au8 biomarker and clinical efficacy data to the FDA for ALS treatment. Key findings include:
1. CNM-Au8 NfL Responders showed significant improvements in survival, functional status, and combined function and survival.
2. Long-term CNM-Au8 treatmentdemonstrated substantial survival benefits compared to matched cont...
Clene Announces New CNM-Au8® Biomarker and Clinical Efficacy Data Submitted to FDA In Support of Treatment For ALS
Clene Inc. (Nasdaq: CLNN) has submitted new CNM-Au8 biomarker and clinical efficacy data to the FDA for ALS treatment. Key findings include:
1. CNM-Au8 NfL Responders showed significant improvements in survival, functional status, and combined function and survival.
2. Long-term CNM-Au8 treatmentdemonstrated substantial survival benefits compared to matched cont...
1
$Clene (CLNN.US)$ i like how i was holding this for the longest time and twos days after i sell, boom shoots up like 🤦♂️
$Clene (CLNN.US)$ wtf mm nearly gave me heart attack for my bday on this massive loss report on a penny stock I spent less than usd100...how can I loss usd480 as if I'm on margin
plz do something about how ur system calculate RS value...![]()
plz do something about how ur system calculate RS value...
2
10
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
$Clene (CLNN.US)$ shitty company 💩
4
$Clene (CLNN.US)$ can someone tell me why the stock is doing so poor these pass few weeks?
2
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Cui Nyonya Kueh :
I Am 102927471 :